Dissimilar adoption Other March 12, 2026 Biosimilars were intended to reduce biologic drug spending by creating competition after patents expire, but unlike small-molecule generics—which often capture…
Drifter Breast April 11, 2023 Top Line: SB3 (aka Ontruzant) is a trastuzumab biosimilar that turned the Herceptin market on its head with FDA approval…
